The dengue virus NS5 protein as a target for drug discovery

被引:173
|
作者
Lim, Siew Pheng [1 ]
Noble, Christian G. [1 ]
Shi, Pei-Yong [1 ]
机构
[1] Novartis Inst Trop Dis, Singapore 138670, Singapore
关键词
Dengue virus; Dengue hemorrhagic fever; NS5; protein; Methyltransferase; RNA polymerase; Antiviral; DEPENDENT RNA-POLYMERASE; AMINO-ACID-RESIDUES; CRYSTAL-STRUCTURE; METHYLTRANSFERASE DOMAIN; NUCLEAR-LOCALIZATION; PHENOTYPIC CHARACTERIZATION; RATIONAL DESIGN; FLAVIVIRUS; CAP; INHIBITOR;
D O I
10.1016/j.antiviral.2015.04.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The non-structural protein 5 (NS5) of flaviviruses is the most conserved amongst the viral proteins. It is about 900 kDa and bears enzymatic activities that play vital roles in virus replication. Its N-terminal domain encodes dual N7 and 2'-O methyltransferase activities (MTase), and possibly guanylyltransferase (GTase) involved in RNA cap formation. The C-terminal region comprises a RNA-dependent RNA polymerase (RdRp) required for viral RNA synthesis. Both MTase and RdRp activities of dengue virus NS5 are well characterized, structurally and functionally. Numerous crystal structures of the flavivirus MTase and RdRp domains have been solved. Inhibitors of both functions have been identified through screening activities using biochemical and cell-based assays, as well as via rational design approaches. This review summaries the current knowledge as well as prospective views on these aspects. This article forms part of a symposium on flavivirus drug discovery in Antiviral Research. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:57 / 67
页数:11
相关论文
共 50 条
  • [1] Proposing drug fragments for dengue virus NS5 protein
    Alhossary, Amr
    Awuni, Yaw
    Kwoh, Chee Keong
    Mu, Yuguang
    JOURNAL OF BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, 2018, 16 (03)
  • [2] Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discovery
    Ramharack, Pritika
    Soliman, Mahmoud E. S.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2018, 36 (05): : 1118 - 1133
  • [3] Virtual Screening of Drug-Like Compounds as Potential Inhibitors of the Dengue Virus NS5 Protein
    Garcia-Ariza, Leidy L.
    Rocha-Roa, Cristian
    Padilla-Sanabria, Leonardo
    Castano-Osorio, Jhon C.
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [4] Conformational Hotspots of Dengue Virus NS5 RdRp
    Khan, Fawad
    Ahmad, Ashfaq
    Ali, Abid
    Ali, Syed Shujait
    Rehman, Tayyab Ur
    CURRENT BIOINFORMATICS, 2018, 13 (03) : 310 - 318
  • [5] The Dengue Virus NS5 Protein Intrudes in the Cellular Spliceosome and Modulates Splicing
    De Maio, Federico A.
    Risso, Guillermo
    Iglesias, Nestor G.
    Shah, Priya
    Pozzi, Berta
    Gebhard, Leopoldo G.
    Mammi, Pablo
    Mancini, Estefania
    Yanovsky, Marcelo J.
    Andino, Raul
    Krogan, Nevan
    Srebrow, Anabella
    Gamarnik, Andrea V.
    PLOS PATHOGENS, 2016, 12 (08)
  • [6] Designing cyclopentapeptide inhibitor as potential antiviral drug for dengue virus ns5 methyltransferase
    Idrus, Syarifuddin
    Tambunan, Usman Sumo Friend
    Zubaidi, Ahmad Ardilla
    BIOINFORMATION, 2012, 8 (08) : 348 - 352
  • [7] Insights into the Binding of the Dengue Virus Nonstructural 5 (NS5) Protein to Stem Loop A (SLA)
    Obi, Juliet
    Fields, James
    McQueen, Linfah
    Deredge, Daniel
    FASEB JOURNAL, 2022, 36
  • [8] Serotype-Specific Regulation of Dengue Virus NS5 Protein Subcellular Localization
    Cheng, Colin Xinru
    Tan, Min Jie Alvin
    Chan, Kitti Wing Ki
    Choy, Milly Ming Ju
    Roman, Noelia
    Arnold, Daniel D. R.
    Bifani, Amanda Makha
    Kong, Sean Yao Zu
    Bist, Pradeep
    Nath, Babu K.
    Swarbrick, Crystall M. D.
    Forwood, Jade K.
    Vasudevan, Subhash G.
    ACS INFECTIOUS DISEASES, 2024, 10 (06): : 2047 - 2062
  • [9] La protein binds to NS5 and NS3 and to the 5′ and 3′ ends of Dengue 4 virus RNA
    García-Montalvo, BM
    Medina, F
    del Angel, RM
    VIRUS RESEARCH, 2004, 102 (02) : 141 - 150
  • [10] Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design
    Benmansour, Fatiha
    Trist, Iuni
    Coutard, Bruno
    Decroly, Etienne
    Querat, Gilles
    Brancale, Andrea
    Barral, Karine
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 865 - 880